FOREST LABORATORIES INC
10-Q/A, 1994-12-22
PHARMACEUTICAL PREPARATIONS
Previous: FLUKE CORP, 10-Q/A, 1994-12-22
Next: FOURTH FINANCIAL CORP, S-4/A, 1994-12-22




                                   FORM  10-Q/A

                       SECURITIES AND EXCHANGE COMMISSION

                            Washington, D.C.  20549

                       __________________________________

(Mark One)
  ---    
/  X /         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
 ---           SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 1994

  ---      
/    /         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
 ---           SECURITIES EXCHANGE ACT OF 1934


For the transition period from _________ to ______________________________      
 

                               Commission File No. 1-5438

                                FOREST LABORATORIES, INC.                      
- ----------------------------------------------------------------------------
                 (Exact name of registrant as specified in its charter)

            Delaware                                         11-1798614     
- --------------------------------                         --------------------
(State or other jurisdiction of                          (I.R.S. Employer
 incorporation or organization)                          Identification No.)
                                                                            
150 East 58th Street
- --------------------

  New York, New York                                              10155-0015 
- --------------------                                              ----------
(address of principal                                             (Zip Code)
  executive office)

Registrant's telephone number, including area code              212-421-7850 
                                                                ------------ 

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.

                       Yes    X           No            
                            -----             -----
Number of shares outstanding of Registrant's Common Stock as of
November 10, 1994:  45,015,558.
<PAGE>
                                  SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant hasduly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.


Date:  December 22, 1994



                                  Forest Laboratories, Inc.
                                  -------------------------
                                  (Registrant)



                                  /s/ Howard Solomon       
                                  ------------------------- 
                                  Howard Solomon
                                  President and Chief
                                  Executive Officer



                                  /s/ Kenneth E. Goodman   
                                  --------------------------
                                  Kenneth E. Goodman
                                  Vice President - Finance



                             


















                                     -2-


<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000038074
<NAME> MICHAEL V. GOMES
       
<S>                             <C>
<PERIOD-TYPE>                   QTR-2
<FISCAL-YEAR-END>                          MAR-31-1995
<PERIOD-END>                               SEP-30-1994
<CASH>                                         132,888
<SECURITIES>                                         0
<RECEIVABLES>                                  129,158
<ALLOWANCES>                                     5,035
<INVENTORY>                                     39,347
<CURRENT-ASSETS>                               319,357
<PP&E>                                          89,235
<DEPRECIATION>                                  22,856
<TOTAL-ASSETS>                                 680,182
<CURRENT-LIABILITIES>                           53,428
<BONDS>                                              0
<COMMON>                                         4,726
                                0
                                          0
<OTHER-SE>                                     621,810
<TOTAL-LIABILITY-AND-EQUITY>                   680,182
<SALES>                                        188,330
<TOTAL-REVENUES>                               193,081
<CGS>                                           35,525
<TOTAL-COSTS>                                  104,368
<OTHER-EXPENSES>                                15,794
<LOSS-PROVISION>                                   540
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 72,919
<INCOME-TAX>                                    26,210
<INCOME-CONTINUING>                             46,709
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    46,709
<EPS-PRIMARY>                                     1.01
<EPS-DILUTED>                                     1.00
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission